Empagliflozin is an antidiabetic medication used to improve glucose control in people with type 2 diabetes, used to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease, used to reduce the risk of death and hospitalization in people with heart failure and low ejection fraction, and used to reduce the risk of cardiovascular death and hospitalization for heart failure in adults.It can be prescribed instead of metformin and has benefits over sulfonylureas.It may be used together with other medications such as metformin or insulin.It is not recommended for type 1 diabetes.It is taken by mouth.